Introduction
The herpes simplex virus type 1 (HSV-1) specified glycoprotein gC-1 is participating in two processes important for the pathophysiology of the virus. First, gC-1, and in addition but possibly less efficiently glycoprotein gB-1, is responsible for the attachment of HSV-1 to cell surface heparan sulfate (HS) (WuDunn and Spear, 1989; Herold et al., 1991; Lycke et al., 1991) . Second, gC-1 may act as a receptor for factor C3b of the human complement system (Friedman et al., 1984) , thereby significantly contributing to evasion from immune responses . Peptide stretches involved in HS-binding as well as C3b-binding have been mapped and shown to be partly overlapping (Hung et al., 1992; Trybala et al., 1994) . Thus, determinants important for HS-binding, situated in close vicinity to C3b-binding domains, were identified in an arginine-rich region preceding aa150 and another region close to aa247 (Trybala et al., 1994) , but the C3b-binding was in addition dependent of two more regions, situated in the C-terminal direction of gC-1 (Hung et al., 1992; Rux et al., 1996) . A schematic representation of gC-1 is given in Figure 1 .
The majority of B-cell epitopes of gC-1 are localized in two antigenic sites (designated I and II) of gC-1 (Marlin et al., 1985) , but the two peptide stretches identified in our study to be engaged in HS-binding are both localized in site II (Trybala et al., 1994) ( Figure 1 ). We found that one site II-specific antibody, designated B1C1 (characterized previously in our laboratory; Olofsson et al., 1983) , inhibited the HSV-1 interaction with cell surface HS by at least one order of magnitude more efficiently than other site II-specific antibodies (Trybala et al., 1994) . Moreover, Mab B1C1 also efficiently blocks the interaction of gC-1 with C3b-coated erythrocytes (Huemer et al., 1989) . Hence, the epitope defined by B1C1 (designated EpB1C1 below) constitutes a strategic structural determinant in a gC-1 domain of importance for the HS-binding as well as the C3b-binding ability of HSV-1.
To obtain further information about the epitope, defined by Mab B1C1 (EpB1C1), we subjected HSV-1 to a strong selection pressure by passing virus in the presence of the antibody, and several B1C1-resistant clones were isolated (Bergström et al., 1992) . Here, we have analyzed gC-1 from one mutant representing a majority of mar mutants, displaying only one single point mutation in the gC-1 gene, resulting in elimination of one single N-glycosylation site of the HS-binding domain, also accompanied by physical loss of one complex type N-linked glycan. Altogether, the results indicated that this particular glycosylation site is of essence for the antigenic behavior of a gC-1 domain involved in the biological activities of this glycoprotein.
Results

Characterization of gC-1 from B1C1-resistant HSV-1 mutant
HSV-1 mutants resistant to Mab B1C1 were selected and plaque-purified as previously described (Bergström et al., 1992) . One typical mutant virus clone, designated HSV-1 2762/B1C1B4.2 was chosen for further experimentation and this clone demonstrated an infectious titer of 10 6.8 compared with the wild type titer 10 7.5 for wild type virus, indicating that acquisition of B1C1 resistance by HSV-1 only slightly impaired its infectivity. To determine the effect of the induced mutation on gC-1 surface expression, we assayed the reactivity of cell surface-associated gC-1 reactivity of HSV-1 infected cells in an ELISA system. As a control we used Mab C13, reacting with an another epitope of Fig. 1 . Schematic structure of gC-1. The insert shows the amino acid sequence surrounding the N-linked glycan at position 148. The silhouette mimics the van der Waal surface of a diantennary complex type N-linked glycan and its size is adjusted to correspond to the distance between adjacent amino acids in the peptide linkage. The disulfide bonding is according to the report by Kihuchi et al. (1984) . The positions of EpC13 as well as antigenic sites I and II are indicated. The lollipops and the hatched box show the positions of N-and O-linked glycans, respectively. The data behind the mapping positions of O-linked glycans and other structural elements of gC-1 is reviewed in Olofsson (1992). antigenic site II in the vicinity of the B1C1 epitope (Sjöblom et al., 1987; Olofsson et al., 1991) , and this antibody reacted equally well with surface-associated gC-1 from wild type virus-infected and mutant-infected cells (Figure 2 ). This shows that the mutation induced by the applied selection pressure of B1C1 did not impair intracellular transport of gC-1 to the plasma membrane. B1C1 on the other hand reacted well in ELISA with gC-1 expressed from wild type-infected cells but did not produce any detectable ELISA signal at all with the mutant virus-infected cells. This result indicated that the EpB1C1 was destroyed by the mutation or rendered inaccessible from membrane-associated gC-1, whereas the adjacent or possibly overlapping EpC13 is fully accessible.
This phenomenon was further explored by RIPA, using [ 3 H]-GlcN-labeled extracts from HSV-1 2762 or HSV-1 2762/B1C1B4.2 -infected cells (Figure 3 ). In addition to MAb C13, we also used another monoclonal antibody, C4H11, specific for a site II epitope of gC-1 (Bergström et al., 1992) . Both C13 and C4H11 precipitated wild type gC-1 as well as mutant gC-1 but the mutant bands had a slightly higher electrophoretic mobility than corresponding wild type band, suggesting structural differences between the proteins ( Figure 3B) . Again a quite different picture was observed for B1C1, which only precipitated the wild type gC-1 ( Figure 3A) . Although care was taken not to analyze less mutant gC-1 than wild type gC-1 radioactivity, no detectable blackening at all was found at the position for mutant gC-1, when B1C1 was used for precipitation. Altogether, these data demonstrated that the mutation induced a complete elimination of EpB1C1 but without affecting the nature of either EpC13 nor EpC4H11.
In previous studies we found that Mab B1C1 inhibits the gC-dependent HS-binding ability of HSV-1 (Svennerholm et al., 1991; Trybala et al., 1994) . Using the ELISA assay by Svennerholm et al. (1991) , we confirmed that the induced elimination of EpB1C1 of HSV-1 2762/B1C1B4.2 also was associated with a corresponding resistance of mutant virus attachment to be blocked by B1C1 (Figure 4 ). It was found that the attachment to BHK-21 cells of HSV-1 2762 over a 60 min observation period was significantly reduced by incubation of B1C1 compared with mock treatment. In contrast, the attachment curves of B1C1-treated and mock-treated HSV-1 2762/B1C1B4.2 to BHK-21 were overlapping, indicating no detectable B1C1-induced inhibition of mutant virus attachment. Both the HSV-1 2762 and HSV-1 2762/B1C1B4.2 preparation produced an ELISA signal of 1.0 AU per added 2 × 10 6 PFU after 1 h of adsorption to BHK cells, indicating a similar PFU/particle ratio of both preparations. Thus, the resistance of mutant gC-1 to react with B1C1 as determined by ELISA and immunoprecipitation was paralleled by a corresponding resistance of mutant virus attachment to be blocked by this antibody.
Identification of point mutation, causing B1C1 resistance to gC-1
To determine the genotypic change of mutated gC-1, we subjected the gC-1 gene of both HSV-1 2762 or HSV-1 2762/B1C1B4.2 to sequencing ( Figure 5 ). The only mutation found was a change of a C at nucleotide 450, substituting Thr150 for an Ile, destroying the glycosylation site at Asn 148. Indeed, the higher electrophoretic mobility of mutant gC-1 (Figure 3 ) than wild type gp120 suggests that this glycosylation site actually is occupied by one N-linked glycan in wild type gC-1. Three B1C1-resistant clones were sequenced and all of them exhibited the same mutation causing change of Thr150 to Ile. 
Confirmation that B1C1 resistance mutation implies physical loss of N-linked glycan
To confirm that the induced mutation resulted in a loss of an N-linked glycan, we labeled wild type and mutant-infected cells with [ 35 S]-Met and subjected cellular extract to RIPA and subsequent digestion with N-glycanase prior to SDS-PAGE ( Figure 6 ). For mock-treated gC-1 preparations the same difference in mobility between wild type gC-1 and mutant gC-1 persisted (see Figure 3) . A corresponding difference in mobility was also noted for mutant and wild type pgC, corresponding to respective precursor containing only high mannose-type Nlinked glycans (Olofsson et al., 1983) . However, for the N-glycanase treated preparations, consisting of the "gC" band (containing O-linked glycans but devoid of N-linked glycans) and the "pgC" band (devoid of N-linked as well as O-linked glycans; Olofsson et al., 1983; Lundström et al., 1987) another pattern appeared. Mobility differences were noted between wild type and mutant gC1 neither regarding the "gC" band nor the "pgC" band. In other words, N-glycanase treatment leveled the difference in mobility between both species of mutant and wild type gC. These data prove that the mutation of the glycosylation site indeed resulted in the physical loss of one single N-linked glycan. were treated with Mab B1C1 (250 µg/ml) and allowed to adsorb to confluent BHK cells in 96 well microplates. Attachment was interrupted at intervals indicated in the figure and the amount of virus was assayed, using a biotinylated gB-specific Mab in an ELISA format. 
Structural class of N-linked glycan eliminated in B1C1-resistant mutant
To determine the nature of the glycan affected by the mutation of the present study, we digested radiolabeled HSV-1 glycoproteins with Endo H, known to selectively release high mannose glycans (Tarentino and Plummer, 1994) . The effect of the enzyme was evaluated by examination of shift in electrophoretic mobility in SDS-PAGE after enzyme digestion. We included two controls to ensure that the Endo H used was sufficient to release high mannose glycans under the current experimental conditions: radiolabeled HIV-1 specified glycoprotein gp120, containing numerous high mannose glycans (Leonard et al., 1990) , was used and subjected to PnGase-or mock-treatment followed SDS-PAGE. The positions of precursor and completely glycosylated gC-1 from wild type (gC and pgC, respectively) and from mutant gC ("gC" and "pgC," respectively) are indicated.
as an external standard ( Figure 7A ). HSV-1 specified gB contains high mannose glycans (Wenske et al., 1982) , and therefore we precipitated lysates from HSV-1 2762 -infected cells with a mixture of a gB-1 specific antibody and MAb C2H11 in the Endo H assay to obtain an adequate internal standard ( Figure 7B ). As expected, the Endo H treatment resulted in a distinct shift of the external standard gp120 band as well as the gB-1 band to higher eletrophoretic mobilities, whereas the gC band did not change its position (Figure 7 ). Because the resolution of the SDS-PAGE allows detection of disappearance of as little as one N-linked glycan of gC-1 (Figures 3 and 5) , our data demonstrated that all glycans of mutant as well as wild type gC-1 are of the complex type. These results for wild type gC-1 are in accordance with the data of Wenske et al. (1982) .
The nature of PNGase-released glycans from gC-1 of HSV-1 2762 or HSV-1 2762/B1C1B4.2 was further analyzed by NPP-HPLC, resolving glycans depending of their number of exposed hydroxyls (Baenziger, 1994) (Figure 8 ). The elution profiles were in many respects similar for both wild type and mutant gC-1 oligosaccharides, indicating presence of moderately branched (comigrating with the LCA-binding marker glycans), bisected (comigrating with E-PHA-binding markers), and tetraantennary glycans (comigrating with L-PHA-binding markers). The data show that the reduction of the number of glycosylation sites by one does not significantly change the size distribution of N-linked glycans of gC-1 and the finding that wild type gC-1 contains complex type glycans ranging from di-antennary to tetra-antennary structures are in accordance with previously published results .
Is EpB1C1 dependent on the glycan of Asn148?
The disappearance of EpB1C1 was indeed associated by an elimination of an N-glycosylation site, but the question still remained open whether the glycan itself was a essential for the epitope or if Thr150 constitutes an essential part of EpB1C1 and that loss of the glycan was a mere passenger phenomenon. To solve this problem we created a mutant virus, designated HSV-1 gCN148A , where the glycosylation site of Asn148 was eliminated the alternative way, i.e., by substituting Gln for Asn, and analyzed cells infected with mutant virus by RIPA (Figure 9) . A virus mutant designated HSV-1 gCrescue , with wild type gC-1 genotype, constructed simultaneously as HSV-1 gCN148A was also analyzed. We found that gC-1 from HSV-1 gCN148A as well as gC-1 from HSV-1 gCrescue -infected cells were precipitated by B1C1 whereas gC-1 derived from HSV-1 2762/B1C1B4.2 as expected was not precipitated by B1C1. The control antibodies to gB-1 and gC-1 precipitated glycoproteins from cells infected with all four variants of HSV-1, indicating that sufficient amounts of viral glycoproteins were produced. These results indicated that Thr150 of the glycosylation site rather than the Asn148 glycan itself was the determinant of EpB1C1.
Although this experiment demonstrated a key role of Thr150, it is still conceivable that the glycan also contributes to the integrity of EpB1C1 by stabilizing some essential local conformation. Indeed, elimination of single N-linked glycans have in some instances caused severe changes in the local conformation of membrane glycoproteins, discernible by spectroscopic methods such as circular dichroism (Wyss et al., 1995) . To identify possible such changes also in the present system, we analyzed gC-1 produced in cells infected with HSV-1 2762/B1C1B4.2 or HSV-1 2762/B1C1B4.2 by CD (Figure 10 ). Due to problems with precipitation of the sample at CD conditions, it was difficult to determine the exact concentration of the samples. Therefore, the spectra were superimposed to try to detect any changes in the shape of the spectra. The spectra obtained were congruent suggesting that the substitution of an Ile for Thr150 of gC-1 did not introduce major changes in the secondary structure of gC-1, confirming the role of Thr150 as a direct determinant of EpB1C1
Discussion
Two peptide stretches of gC-1, situated in the vicinity of N148 and G247, respectively, are constituents of the C3b-binding as well as the HS-binding region, most likely forming a three-dimensional functional domain (Hung et al., 1992; Trybala et al., 1994; Rux et al., 1996) . Mab B1C1, binding to a conformational epitope of gC-1, is an efficient blocker of the C3b-binding as well as the HS-binding ability of gC-1 (Huemer et al., 1989; Trybala et al., 1994) , indicating that this epitope is a central structural element of a C3b-and HS-binding domain. The principal conclusion of the present article is that B1C1-binding ability of gC-1 is strictly dependent on the presence of T150, which in turn is a constituent of an utilized glycosylation site, equipped with a complex N-linked glycan at N148.
We found that elimination of this glycosylation site by substituting I for T150 resulted in a complete loss of EpB1C1, as demonstrated by various techniques, and one explanation could be that this N-linked glycan in one way or another was necessary for binding of Mab B1C1 to gC-1. There are several examples of viral and cellular membrane glycoproteins containing multiple N-linked glycans where only one or possibly a few strategic sites but not the others are of especial importance for the functional conformation of the glycoprotein. In some cases, the significance of such N-linked glycans is associated with intracellular folding of the glycoprotein in question (Vidal et al., 1989; Ng et al., 1990) by virtue of their ability to interact with molecular chaperones such as calreticulin (Otteken and Moss, 1996) and calnexin (Hammond et al., 1994) , thereby being essential only transiently during folding. For some glycoproteins including ligand binding of I-type human lectins such as CD22 and CD33 (Sgroi et al., 1996) , CD46 as a measles virus receptor (Maisner et al., 1996) , and the CD59-binding factor, CD2 (Wyss et al., 1995) , the presence of single, defined N-linked glycans seem to be required continuously for stabilization of the functional conformation of the protein. However, our finding that elimination of the N148 glycosylation site from gC-1 via the alternative way, i.e., mutating N148 rather than T150, is compatible with full binding to B1C1, although surprising, clearly demonstrated that T150 in it self is essential for the integrity of B1C1 and that the loss of the N-linked is a passenger phenomenon without relevance for the gC-1 binding to B1C1.
The data therefore show that T150 without any involvement of an adjacent N-linked glycan is important for EpB1C1. But, besides from being directly engaged in gC-1 binding to B1C1, T150 could be a an indirect contributor to gC-1 binding by presenting a crucial O-linked glycan. It is well established that antigenic site II contains several clustered and single O-linked glycans associated with serine or threonine residues but the exact positions of Thr and Ser residues associated with N-linked glycans have not yet been identified (Olofsson et al., 1981 (Olofsson et al., , 1983 Dall'Olio et al., 1985; Lundström et al., 1987) . However, treatment with O-glycanase did not significantly alter the binding of gC-1 to B1C1 (unpublished observations). Moreover, we analyzed the gC-1 amino acid sequence in the artificial neural network O-glycosylation prediction algorithm NetOGlyc 2.0, developed by Hansen et al. (1997 Hansen et al. ( , 1998 , but this analysis was strongly indicative that T150 was not O-glycosylated (O-glycosylation potential 0.0085; threshold 0.71). These data would suggest that T150 in it self is a part of Ep B1C1, either by being a part of the B1C1-binding paratope of gC-1 or indirectly, by stabilizing the complex three-dimensional conformation of this domain, probably involving four separate peptide loops (Rux et al., 1996) . However, the CD data do not provide any evidence for T150-induced influence on the secondary structure of gC-1 (Figure 10) . Moreover, our finding that monoclonal antibodies to other adjacent conformational site II epitopes were binding to mutant as well as wild type gC-1 suggests that T150 via its side chain is directly responsible for binding of gC-1 to B1C1.
The adjacent peptide environment of the N148 glycan is engaged in more than one biological activity. Besides T150, determining the integrity of EpB1C1, the amino acid residues situated immediately upstreams of the N-linked glycan, R143, R145, and R147, are involved in gC-1 binding to heparan sulfate (Trybala et al., 1994) , and they must therefore be easily accessible (see Figure 1) . It is well accepted that complex type glycans are extremely voluminous with capacity to cover a substantial part of the surrounding peptide surface (Montreuil, 1987) . The present data therefore reveals a paradox inasmuch as the significant covering capacity of N-linked glycans may be combined with possibility to expose biologically active amino acids situated immediately adjacent to, or even within the glycosylation site.
A final comment should be made on mutant analysis for determination of the biological roles of N-linked glycans of particular glycosylation sites. Our data reflect a situation where major changes in the biological activity of a viral glycoprotein, caused by mutagenic elimination of glycosylation site, are totally associated with the change of the hydroxy amino acid of the glycosylation site and the loss of a large complex type glycan seems to be a passenger phenomenon only, without any biological relevance. Thus, it is strongly recommended that conclusions on the significance of N-linked glycans of particular glycosylation sites should include analysis of both glycoprotein mutants with modified asparagine and modified hydroxyaminoacid, respectively.
Materials and methods
Cells, monoclonal antibodies, and viruses
African green monkey kidney (GMK-AH1; Günalp, 1965 ) cells were grown in Eagle's minimum essential medium (MEM) supplemented with 2% calf serum, 100 U of penicillin per ml, and 100 mg of streptomycin per milliliter. Baby hamster kidney (BHK-21; ATCC CRL-6282) cells were grown in Glasgow minimum essential medium supplemented with 8% calf serum, 8% tryptose phosphate broth, 1 mM, L-glutamine and antibiotics as above. Three monoclonal antibodies against gC-1 were used: monoclonal antibody (Mab) B1C1, defining an carbohydratemodulated antigenic site II epitope (Olofsson et al., 1983; Sjöblom et al., 1987) , and an efficient blocker of gC-1 interaction with cell surface heparan sulfate (Trybala et al., 1994) , Mab C4H11, defining an carbohydrate-independent epitope of site II (Bergström et al., 1992) , and Mab C13 recognizing an antigenic site II epitope in the vicinity of the HS-binding region of gC-1 (Figure 1) (Wu et al., 1990; Trybala et al., 1993) . The HSV-1 strains used were HSV-1 2762 (Bergström et al., 1990) and an isolated monoclonal antibody-resistant (mar) mutant virus HSV-1 2762/B1C1B4.2 , resistant to Mab B1C1 (Bergström et al., 1992) . The mutant HSV-1 strain HSV-1 gCN148A , where Ala was substituted for Asn148, and the corresponding rescue strain HSV-1 gCrescue were constructed as described elsewhere (Mårdberg, unpublished observations). In some control experiments a monoclonal antibody B11D8, specific for gB-1 was used (Bergström et al., 1992) .
Detection of infected cell-surface gC-1
Detection of cell surface-associated HSV-1 antigens was performed essentially as described previously . Briefly, 96-well plates, containing GMK cells, were infected with 10 4 PFU/well, and incubated at 37_C for 24 h. Subsequently the cells were washed and fixed with 0.25% glutaraldehyde in PBS for 10 min at room temperature. Thereafter, the cells were washed repeatedly and blocked with 2% bovine serum albumin in PBS. The cells were incubated with anti-gC-1 antibodies, and the binding was quantitated by ELISA as described previously .
Circular dichroism (CD) spectroscopy
Glycoprotein C was purified from HSV-1 2762 or HSV-1 2762/B1C1B4.2 -infected cell, respectively, by immunosorbent chromatography as described previously (Olofsson et al., 1983) . The infected cells were solubilized in lauryl maltoside prior to purification. The glycoproteins were diluted in 1 mM potassium phosphate-buffer, pH 7.4, containing 0.05% w/v lauryl maltoside; prior to CD spectroscopy being performed as described previously (Wittung et al., 1994; Leckner et al., 1997) . Spectra from 200 to 260 nm were recorded in a 1 mm cell in a Jasco J720 spectrapolarimeter. The sample compartment was purged with nitrogen.
Attachment assay
The attachment assay was carried out in an ELISA format essentially as described by Svennerholm et al. (1991) . Briefly, 2 × 10 7 PFU/ml HSV-1 2762 or HSV-1 2762/B1C1B4.2 were incubated with purified MAb B1C1 at a concentration 250µg/ml in 3.5 ml MEM, vortexed for 10 s and incubated at +4_C for 45 min. Aliquots of about 200 µl were added to confluent cultures of freshly washed BHK-21 cells in 96 well tissue culture plates and incubated at 37_C. The virus suspensions were withdrawn after 0, 15, 30, and 60 min, respectively, and replaced by Eagle MEM. Virus-cell incubations were performed in quadruplicate. After incubation, the cells were fixed for 15 min with 160 µl 0.25 glutardialdehyde, washed in Hank's balanced solution without phenol red, and processed for ELISA.
Metabolic labeling of HSV-1 glycoproteins
Confluent layers of GMK cells in 6-well culture plates were washed two times with serum-free MEM and infected with HSV-1 2762 or HSV-1 2762/B1C1B4.2 at a m.o.i. of 3. The virus was allowed to adsorb to the cells for 1 h at 37_C, followed by addition of MEM, containing antibiotics. After incubation in CO 2 -incubator for 4 h 50µCi/ml D-[6-3 H]-glucosamine hydrochloride ([ 3 H]-GlcN; Amersham, 30 Ci/mmol) was added. The cells were radiolabeled for 20 h until harvest. The labeled culture supernatant was removed from cells and supplemented with 1% (v/v) NP40 and 1 mM AEBSF (4-(2-aminoethyl)-benzesulfonyl, HCL:p-aminoethylbenzenesulfonyl fluoride, HCl; Calbiochem/ Novabiochem). Cells were detached from culture vessel using rubber policemen, washed twice with TBS (Tris-buffered saline; 150 mM NaCl, 50 mM Tris HCL, pH 7.5) and resuspended in 1 ml TBS containing, 1% (v/v) NP40 and 1 mM AEBSF. Cell suspensions were sonicated on ice followed by centrifugation to remove cell debris.
Radioimmunoprecipitation
Radioimmunoprecipitation was carried out essentially as previously described (Olofsson et al., 1986) . Heat-inactivated formalin-fixed S.aureus, coated with anti-mouse antibodies (Dakopatts), were mixed with anti-HSV-1gC-specific mouse monoclonal antibodies B1C1 or C4H11B for 2 h at 4_C. The antibody-staphylococcus complex was then washed three times in TTB (TBS, containing 1% Triton X-100 and 0.1% bovine serum albumin (BSA)) and mixed with labeled culture supernatants or labeled cell lysates overnight at 4_C. The samples were washed twice in TTB and twice in TBS prior to analysis by SDS-PAGE (9.25% polyacrylamide gels) and fluorography (Amersham).
N-Glycosidase (PnGase) digestion of immunoprecipitated glycoproteins
[ 35 S]-Labeled culture supernatants were immunoprecipitated as described above but after final wash the samples were resuspended in 10 µl 20 mM sodium phosphate buffer, pH 7.5, containing 10 mM EDTA, 0.005% sodium azide, 1% (v/v) β-mercaptoethanol, 1% (w/v) sodium dodecyl sulfate (SDS) and incubated for 20 min at 37_C. The glycoprotein was denatured and eluted from the Staphylococci by boiling for 5 min followed by centrifugation. The samples were then diluted 10 times in 20mM sodium phosphate buffer pH 7.5 containing, 10 mM EDTA, 10 mM sodium azide, 1% (v/v) β-mercaptoethanol, 2% (v/v) NP40 to avoid SDS denaturation of PnGase. PnGase (6 µl of 200IU/ml; Boehringer Mannheim) was added to samples prior to incubation at 37_C for 20 h, as described previously (Bolmstedt et al., 1992) . The samples were then precipitated by incubation with 1 ml ice cold (-20_C) acetone for 2 h and centrifugation at 11,000 r.p.m. for 10 min. The pelleted samples were finally analyzed on SDS-PAGE and autoradiography (Amersham).
Endoglycosidase H (Endo H) digestion
Endo H digestion was performed essentially as described previously . Thus, [ 3 H]-GlcN labeled culture supernatants were immunoprecipitated as described above but for the final wash was used 1 ml 0.5 M sodium citrate buffer, pH 5.5, containing 0.1 M β-mercaptoethanol and 0.8% (w/v) SDS. The glycoproteins were denatured and eluted from the staphylococcal cells by resuspending the samples in 25 µl of the same citrate buffer and boiling for 5 min. Prior to enzyme digestion, 15 µl 0.5 M sodium citrate buffer, pH 5.5, 75 µl water, and 5 µl 100 mM phenyl methyl sulfonylfluoride (PMSF) was added to the samples and the staphylococcal cells were removed by centrifugation. Endo H (20 µl 1 mU/ml; Boehringer-Mannheim) was added to the samples followed by incubation at 37_C for 20 h. The samples were then precipitated by incubation with 1 ml ice cold (-20_C) acetone for 2 h and centrifugation at 11,000 r.p.m. for 10 min. The pelleted samples were finally analyzed on SDS-PAGE and fluorography (Amersham).
Glycosidase treatment and HPLC-analysis of released glycans
Immunosorbent-purified, [ 3 H]-GlcN-labeled gC-1 from HSV-infected cells was desialylized with excess of neuraminidase as described previously . Briefly, the samples were concentrated in sialidase buffer (50 mM sodium acetate, 1 mM CaCl 2 , pH 5.5) with Microsep 30K microconcentrators (Filtron, Gothenburg, Sweden) and digested with 0.1 U neuraminidase (Behringwerke) for 3 h at 37_C. The desialylized glycoprotein was subjected to treatment with N-glycanase or Endo H as described above. Fifty micrograms purified [ 3 H]-GlcN-labeled gC-1 was denatured by boiling for 2 min in N-glycanase or Endo H buffer (see above), respectively, prior to enzyme treatment. After centrifugation, the liquid phase was analyzed by normal phase partition HPLC (NPP-HPLC) (Baenziger, 1994) , using TSK gel Amide 80 gel (TosoHaas, Philadelphia, PA) as described by Bolmstedt et al. (Bolmstedt et al., 1997) . The initial phase was 75% acetonitrile in water and a linear gradient of decreasing acetonitrile concentration was applied. The flow rate was 0.5 ml/h at 75_C. A ladder of homoglucose polymers, ranging from monomeric glucose to at least 23-mer, prepared as described by Kobata (1994) and two [ 3 H]-GlcN fucosylated nonsialylated oligosaccharides (di-one tri-antennary, respectively, and characterized by Bio-Gel P4 chromatography (Kobata, 1994) and lectin chromatography (Cummings, 1994) ) were used as standards. Fractions were collected for each minute and assayed for radioactivity by liquid scintillation counting.
Sequencing
Mutant and wild type virus samples from infected cell cultures were diluted 1/100 in distilled water and DNA was released from virions by incubating 100 µl of the samples with 10 µl of 1 M NaOH at 37_C for 1 h and subsequent neutralization with 1 M HCl, according to the procedure by Landgren et al. (1994) . The DNA segment encoding the complete amino acid sequence gC-1 was amplified by PCR, using five consecutive sets of primer pairs, and sequenced by the chain termination method. Each amplicon was analyzed both in the sense and antisense direction, using fluorescent dye terminators. The sequences were read in a ABI Prism automized capillary sequence reader (Applied Biosystems, Foster City, CA) and processed using the Sequence Navigator Software (Applied Biosystems).
